Kindly MD, Inc. (KDLY)
NASDAQ: KDLY · IEX Real-Time Price · USD
3.020
-2.470 (-44.99%)
At close: May 31, 2024, 4:00 PM
3.140
+0.120 (3.97%)
After-hours: May 31, 2024, 7:58 PM EDT

Company Description

KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic.

KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.

Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare.

The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction.

The Company captures all relevant datapoints to assist and appropriately treat each individual patient.

We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America.

Kindly MD, Inc.
Country United States
Founded 2019
IPO Date May 31, 2024
Industry Medical Care Facilities
Sector Healthcare
Employees 21
CEO Timothy Pickett

Contact Details

Address:
5097 South 900 East, Suite 100
Salt Lake City, UT 84117
United States
Phone (385) 388-8220
Website kindlymd.com

Stock Details

Ticker Symbol KDLY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $5.50
CIK Code 0001946573
Employer ID 84-3829824
SIC Code 8000

Key Executives

Name Position
Timothy Pickett Chief Executive Officer, Director
Adam Cox Chief Operating Officer, Director
Jared Barrera Chief Financial Officer

Latest SEC Filings

Date Type Title
May 31, 2024 8-K Current Report
May 31, 2024 424B4 Prospectus
May 31, 2024 424B3 Prospectus
May 31, 2024 CERT Certification by an exchange approving securities for listing
May 15, 2024 424B4 Prospectus
May 15, 2024 424B3 Prospectus
May 13, 2024 EFFECT Notice of Effectiveness
May 13, 2024 8-A12B Registration of securities
May 9, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Apr 9, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933